{
  "id": "64403a5857b1c7a31500004c",
  "type": "factoid",
  "question": "What was the phase of the clinical trial PEACHTREE?",
  "ideal_answer": "The PEACHTREE trial was a phase III clinical trial.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34322164"
  ],
  "snippets": [
    {
      "text": "Recent results from the PEACHTREE trial (ClinicalTrials.gov Identifier: NCT02595398), a phase III trial with two suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks, showed the significant improvement in visual acuity and reduction in central subfield thickness, all without increasing the risk of elevated intraocular pressure or accelerated cataract progression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34322164",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "three, III"
}